Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart Failure

被引:64
作者
Galli, Alessio [1 ]
Lombardi, Federico [1 ]
机构
[1] Univ Milan, Dept Clin & Community Sci, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Cardiovasc Dis Unit, Via F Sforza 35, I-20122 Milan, Italy
关键词
ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR MAGNETIC-RESONANCE; RECOMBINANT HUMAN NEUREGULIN-1; MICROVASCULAR OBSTRUCTION; INTRAMYOCARDIAL HEMORRHAGE; POSTMYOCARDIAL INFARCTION; MATRIX METALLOPROTEINASES; REPERFUSION HEMORRHAGE; FIBER ARCHITECTURE; TASK-FORCE;
D O I
10.1155/2016/2579832
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure is a chronic disease with high morbidity and mortality, which represents a growing challenge in medicine. A major risk factor for heart failure with reduced ejection fraction is a history of myocardial infarction. The expansion of a large infarct scar and subsequent regional ventricular dilatation can cause postinfarct remodelling, leading to significant enlargement of the left ventricular chamber. It has a negative prognostic value, because it precedes the clinical manifestations of heart failure. The characteristics of the infarcted myocardium predicting postinfarct remodelling can be studied with cardiac magnetic resonance and experimental imaging modalities such as diffusion tensor imaging can identify the changes in the architecture of myocardial fibers. This review discusses all the aspects related to postinfarct left ventricular remodelling: definition, pathogenesis, diagnosis, consequences, and available therapies, together with experimental interventions that show promising results against postinfarct remodelling and heart failure.
引用
收藏
页数:12
相关论文
共 122 条
[1]   Mapping arrhythmias in the failing heart: from Langendorff to patient [J].
Akar, Joseph G. ;
Akar, Fadi G. .
JOURNAL OF ELECTROCARDIOLOGY, 2006, 39 (04) :S19-S23
[2]  
[Anonymous], 2014, CIRCULATION, DOI DOI 10.1161/01.cir.0000441139.02102.80
[3]  
Anthony Fauci.S., 2008, HARRISONS PRINCIPLES
[4]   Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors [J].
Antos, CL ;
McKinsey, TA ;
Dreitz, M ;
Hollingsworth, LM ;
Zhang, CL ;
Schreiber, K ;
Rindt, H ;
Gorczynski, RJ ;
Olson, EN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) :28930-28937
[5]   Neurohormonal activation is associated with increased levels of plasma matrix metal loproteinase-2 in human heart failure [J].
Banfi, C ;
Cavalca, V ;
Veglia, F ;
Brioschi, M ;
Barcella, S ;
Mussoni, L ;
Boccotti, L ;
Tremoli, E ;
Biglioli, P ;
Agostoni, P .
EUROPEAN HEART JOURNAL, 2005, 26 (05) :481-488
[6]   Microvascular Obstruction Underlying Pathophysiology and Clinical Diagnosis [J].
Bekkers, Sebastiaan C. A. M. ;
Yazdani, Saami K. ;
Virmani, Renu ;
Waltenberger, Johannes .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (16) :1649-1660
[7]   Left ventricular remodeling after primary coronary angioplasty - Patterns of left ventricular dilation and long-term prognostic implications [J].
Bolognese, L ;
Neskovic, AN ;
Parodi, G ;
Cerisano, G ;
Buonamici, P ;
Santoro, GM ;
Antoniucci, D .
CIRCULATION, 2002, 106 (18) :2351-2357
[8]   Heart Failure [J].
Braunwald, Eugene .
JACC-HEART FAILURE, 2013, 1 (01) :1-20
[9]   Iron toxicity and chelation therapy [J].
Britton, RS ;
Leicester, KL ;
Bacon, BR .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (03) :219-228
[10]   Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation [J].
Carmeliet, P ;
Moons, L ;
Lijnen, HR ;
Baes, M ;
Lemaitre, V ;
Tipping, P ;
Drew, A ;
Eeckhout, Y ;
Shapiro, S ;
Lupu, F ;
Collen, D .
NATURE GENETICS, 1997, 17 (04) :439-444